ID   AMCPAC05
AC   CVCL_JX56
DR   cancercelllines; CVCL_JX56
DR   Cosmic; 2754413
DR   Wikidata; Q54749732
RX   PubMed=28435405;
CC   Population: Korean.
CC   Doubling time: 75 hours (PubMed=28435405).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly60_Gln61insLeu (c.180_181insCTA); Zygosity=Heterozygous (PubMed=28435405).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000045116; Zygosity=Heterozygous (PubMed=28435405).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Lys (c.398T>A); ClinVar=VCV002430159; Zygosity=Unspecified (PubMed=28435405).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
RX   PubMed=28435405; DOI=10.1186/s12935-017-0416-8; PMCID=PMC5397831;
RA   Kim M.-J., Kim M.-S., Kim S.J., An S., Park J., Park H., Lee J.H.,
RA   Song K.-B., Hwang D.W., Chang S., Kim K.-P., Jeong S.-Y., Kim S.C.,
RA   Hong S.-M.;
RT   "Establishment and characterization of 6 novel patient-derived primary
RT   pancreatic ductal adenocarcinoma cell lines from Korean pancreatic
RT   cancer patients.";
RL   Cancer Cell Int. 17:47.1-47.15(2017).
//